Floatz logo

[18F]MC225

Neurodegenerative Diseases

University Medical Center GroningenSmall moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

20 Active assets in the Neurodegenerative Diseases cohort.

Asset / SponsorPhaseRating
Live Combined Bifidobacterium
Beijing Friendship Hospital
Phase 4BB
Lipitor
Monash University
Phase 4BB
Live Combined Bifidobacterium,Lactobacillus And Enterococcus Capsules
Beijing Friendship Hospital
Phase 4BB
Acp-103
Vanderbilt University Medical Center
Phase 4BB
LEVODOPA
Merck Sharp & Dohme LLC
Phase 2B

View all 41 →

Same molecule, other indications

[18F]MC225 is also rated in:

cognitive disorderDormant
CC
Indicative ·
43 / 100
View asset →
Alzheimer diseaseDormant
CC
Indicative ·
41 / 100
View asset →
Parkinson diseaseDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →